ivonescimab investigational

Selected indexed studies

• Antibodies to watch in 2025. (MAbs, 2025) [PMID:39711140]
• Antibodies to watch in 2024. (MAbs, 2024) [PMID:38178784]
• What is on the Horizon Beyond Platinum and Immunotherapy for Patients With Advanced Non-Small Cell Lung Cancer Without Actionable Genomic Aberrations? (JCO Oncol Pract, 2025) [PMID:41418081]

_Worker-drafted node — pending editorial review._